Achaogen, Inc. reported Revenue growth of 8.29% year on year in the fourth quarter 2018, to $ 2.03 millions, this is lower than Achaogen, Inc.'s recent average Revenue improvement of 30.67%.
Looking into fourth quarter 2018 results within Major Pharmaceutical Preparations industry 134 other companies have achieved higher Revenue growth. While Achaogen, Inc.' s Revenue increase of 8.29% ranks overall at the positon no. 1966 in the fourth quarter 2018.
Revenue by Quarter for the Fiscal Years 2015, 2016, 2017, 2018
Achaogen,'s Q/Q Revenue Growth
Revenue Q/Q Growth Statistics
High
Average
Low
223.92 %
19.29 %
-83.04 %
(Dec 31 2017)
AKAO's IV. Quarter Q/Q Revenue Comment
Achaogen, Inc. achieved in the IV. Quarter 2018 below company average Revenue growth of 1.25% quarter on quarter, to $ 2.03 millions.
Within Major Pharmaceutical Preparations industry 155 other companies have achieved higher Revenue quarter on quarter growth. While Achaogen,'s Revenue growth quarter on quarter, overall rank is 2011.
Achaogen, Inc. achieved in the IV. Quarter 2018 below company average Revenue growth of 1.25% quarter on quarter, to $ 2.03 millions.
Within Major Pharmaceutical Preparations industry 155 other companies have achieved higher Revenue quarter on quarter growth. While Achaogen,'s Revenue growth quarter on quarter, overall rank is 2011.
Achaogen,'s 12 Months Revenue Growth Year on Year
Revenue TTM Growth
12 Months Ending (Dec 31 2018)
12 Months Ending (Sep 30 2018)
12 Months Ending (Jun 30 2018)
12 Months Ending (Mar 31 2018)
12 Months Ending (Dec 31 2017)
Cumulative Revenue 12 Months Ending
$ 8.73
$ 8.57
$ 7.15
$ 5.85
$ 11.18
Y / Y Revenue Growth (TTM)
-21.9 %
-57.23 %
-79.86 %
-86.51 %
-73.25 %
Year on Year Revenue Growth Overall
Ranking
# 3552
# 2520
# 3435
# 2203
# 3572
Seqeuential Revenue Change (TTM)
1.82 %
19.87 %
22.13 %
-47.61 %
-44.24 %
Seq. Revenue Growth (TTM) Overall
Ranking
# 3915
# 262
# 221
# 3920
# 1830
Cumulative Revenue growth Comment
Achaogen, showed decline, but improvement compare to trailing twelve month Revenue decrease in Sep 30 2018. If the fiscal year would end in Dec 31 2018, Achaogen,'s annual Revenue drop would be -21.9% year on year to $9 millions.
In the Healthcare sector 413 other companies have achieved higher trailing twelve month Revenue growth. While Revenue growth total ranking has deteriorated compare to previous quarter from 2520 to 3552.
Achaogen, showed decline, but improvement compare to trailing twelve month Revenue decrease in Sep 30 2018. If the fiscal year would end in Dec 31 2018, Achaogen,'s annual Revenue drop would be -21.9% year on year to $9 millions.
In the Healthcare sector 413 other companies have achieved higher trailing twelve month Revenue growth. While Revenue growth total ranking has deteriorated compare to previous quarter from 2520 to 3552.
About Achaogen, Revenue Growth Rates (AKAO), Current and Historic Growth - CSIMarket Analysis
How we calculate this
This page is based on issuer-reported fundamentals and CSIMarket’s U.S. equities database (20+ years).
Growth is computed using year-over-year (Y/Y), sequential, and trailing-twelve-month (TTM) methods.
Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com
Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.
14.49%